CNBX Pharmaceuticals
$0
26
+$0+33.33% Monday 16:20
Statistics
Day High
0
Day Low
0
52W High
0.02
52W Low
0
Volume
1,583,000
Avg. Volume
19,379,266
Mkt Cap
174,153.6
P/E Ratio
0
Dividend Yield
-
Dividend
-
Earnings
12AprExpected
Expected EPS
N/A
Actual EPS
-0.01
Financials
-Profit Margin
Unprofitable0Revenue
-628,000Net Income
People Also Follow
This list is based on the watchlists of people on Stock Events who follow CNBX. It's not an investment recommendation.
Competitors
This list is an analysis based on recent market events. It's not an investment recommendation.
Corbus Pharmaceuticals
CRBP
Mkt Cap148.9M
Tilray Brands
TLRY
Mkt Cap1.5B
Canopy Growth
CGC
Mkt Cap418.51M
Aurora Cannabis
ACB
Mkt Cap280.01M
About
CNBX Pharmaceuticals Inc., a biopharmaceutical company, engages in the discovery, development, and commercialization of cannabinoid-based treatments and therapies for cancer. Its lead product candidate is RCC-33, an oral capsule containing a formulation of cannabinoids for the treatment of colorectal cancer. The company is also developing various drug candidates, including PLP-33 for the treatment of lateral spreading or sessile, and colorectal polyps during colonoscopy; BRST-33 to treat breast cancer; MLN-33 for the treatment of Melanoma; and PRST-33 to treat prostate cancer. In addition, it develops Cannabics SR, a lipid-based capsule containing a standardized formulation of cannabinoids for the treatment of cancer anorexia-cachexia syndrome; and Cannabics CDx, an ex-vivo drug sensitivity test. The company was formerly known as Cannabics Pharmaceuticals Inc. and changed its name to CNBX Pharmaceuticals Inc. in March 2022. CNBX Pharmaceuticals Inc. was incorporated in 2004 and is based in Bethesda, Maryland. CNBX Pharmaceuticals Inc. is a subsidiary of Cannabics Inc.
Show more...
CEO
Mr. Gabriel Yariv
Employees
1
Country
US
ISIN
US13764M2098
Listings
0 Comments
Share your thoughts
FAQ
What is CNBX Pharmaceuticals stock price today?▼
The current price of CNBX is $0 USD — it has increased by +33.33% in the past 24 hours. Watch CNBX Pharmaceuticals stock price performance more closely on the chart.
What is CNBX Pharmaceuticals stock ticker?▼
Depending on the exchange, the stock ticker may vary. For instance, on exchange CNBX Pharmaceuticals stocks are traded under the ticker CNBX.
Is CNBX Pharmaceuticals stock price growing?▼
CNBX stock has risen by +0% compared to the previous week, the month change is a -60% fall, over the last year CNBX Pharmaceuticals has showed a -98% decrease.
What is CNBX Pharmaceuticals market cap?▼
Today CNBX Pharmaceuticals has the market capitalization of 174,153.6
What were CNBX Pharmaceuticals earnings last quarter?▼
CNBX earnings for the last quarter are -0.01 USD per share, whereas the estimation was N/A USD resulting in a N/A surprise. The estimated earnings for the next quarter are N/A USD per share.
What is CNBX Pharmaceuticals revenue for the last year?▼
CNBX Pharmaceuticals revenue for the last year amounts to 0 USD.
What is CNBX Pharmaceuticals net income for the last year?▼
CNBX net income for the last year is -628,000 USD.
How many employees does CNBX Pharmaceuticals have?▼
As of February 10, 2026, the company has 1 employees.
In which sector is CNBX Pharmaceuticals located?▼
CNBX Pharmaceuticals operates in the Health Care sector.
When did CNBX Pharmaceuticals complete a stock split?▼
The last stock split for CNBX Pharmaceuticals was on May 12, 2022 with a ratio of 1:120.
Where is CNBX Pharmaceuticals headquartered?▼
CNBX Pharmaceuticals is headquartered in Bethesda, US.